While TP53 and CDKN2A represent the first and third most commonly mutated genes in the overall TCGA HNSCC cohort, mutations in these genes, respectively, were present in only 23/60 (38.3%) and 3/60 (5%) of Singaporean patients. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.